Viatris
Viatris chief executive officer Scott A. Smith is a deeply knowledgeable senior global biotechnology and pharmaceutical executive with more than 35 years of experience. He is a seasoned builder who possesses vast global commercial and pharmaceutical expertise and a proven ability to build, grow and manage large complex organizations. Before becoming Viatris’ CEO, Smith was President and Chief Operating Officer of Celgene Corp. Most recently, he served as President of BioAtla, Inc., a global biotechnology company focused on the development of Conditionally Active BiologicsTM (CAB) antibody therapeutics. Smith is a member of Viatris board of directors.
This person is not in any teams
This person is not in any offices
Viatris
42 followers
Viatris is a new kind of global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including a global workforce of approximately ~45,000, Viatris aims to deliver increased access to affordable, quality medicines for patients worldwide, regardless of geography or circumstance.